title: [Use of methylphenidate in palliative patients with asthenia: a review].
abstract: Asthenia (or fatigue) is one of the most common symptoms in palliative patients. Methylphenidate is currently being assessed for treating this condition. A review of related literature published to date was performed, revealing methylphenidate to be a safe drug which could decrease fatigue in palliative patients with a tolerable side-effects profile.
authors.affiliation: Servicio Navarro de Salud-Osasunbidea, Unidad de Medicina familiar y Comunitaria de Navarra, Atención Primaria, Centro de Salud de Ermitagaña, Pamplona. ana.saralegui.iglesias@navarra.es
authors.forename: A
authors.initials: A
authors.lastname: Saralegui
authors.forename: P
authors.initials: P
authors.lastname: Palacio
authors.forename: P
authors.initials: P
authors.lastname: Royo
mesh_terms: D001247:Asthenia / Q000188:drug therapy*; D018765:Dopamine Uptake Inhibitors / Q000627:therapeutic use*; D005221:Fatigue / Q000188:drug therapy*; D006801:Humans; D008774:Methylphenidate / Q000627:therapeutic use*; D010166:Palliative Care
chemical_list: D018765:Dopamine Uptake Inhibitors; D008774:Methylphenidate